Document is current
Any future updates will be listed below
-
Authors
Armentaro, Giuseppe
Cassano, Velia
Magurno, Marcello
Pastura, Carlo Alberto
Divino, Marcello
Severini, Giandomenico
Martire, Domenico
Miceli, Sofia
Maio, Raffaele
Mazza, Elisa
Montalcini, Tiziana
Pujia, Arturo
Sciacqua, Angela
-
Funding
Funding for this research was provided by:
Università degli studi "Magna Graecia" di Catanzaro
- License Information
-
More Information
Article History
Received: 14 April 2025
Accepted: 21 April 2025
First Online: 19 May 2025
Declarations
:
: The protocol was approved by the University Ethics Committee (2022.384), and written informed consent was obtained from all participants to the “MAgna GraecIa evaluation of Comorbidities in patients with Heart Failure (MAGIC-HF)” study (ClinicalTrials.gov identifier: NCT05915364) and by the local Ethics Committee of Calabria Region, Italy (Catanzaro, Italy, document n. 263–23 July 2020). This study met the standards of good clinical practice (GCP) and the principles of the Declaration of Helsinki.
: The study is registered at ClinicalTrials.gov (NCT05915364). Researchers wishing to access data should contact the corresponding author.
: The authors declare no competing interests.
